https://www.nature.com/articles/s41590-025-02376-4

https://www.technologynetworks.com/tn/news/how-dying-tumor-cells-alert-the-immune-system-to-fight-cancer-408303

https://phys.org/news/2025-12-nanozigzags-biomaterial-cancer-immunotherapy-efficacy.html

Wow, nice! You called the five cents! Everyone knows the pump has to come. Then the next piece of news and probably down to ten cents. But hey, at least LP can dilute at 30 or 40 cents and keep her word. 🤷‍♀️

They used to call this a “Dead cat bounce” but you don’t hear that much anymore.

60 day timing on the blocker with a 30 day window to the next filing? We shall see.

AF called on the SEC to get involved and semi accused UCLA of conspiring, did he not? Or is that just a normal yawn of day around here for an influential biotech journalist to go that far?

Unlikely to be moving up if real good news were imminent as they’d do one last quick shake out.

Could be that AF motivated someone to end this?

They probably forget about the wash rules.

Still waiting for anyone to dig up anything that might resemble what $consultants$ are allegedly telling her?

>>What is noteworthy, and I would say this is based on what our UK advisors have said to us, we don’t have firsthand knowledge, but our advisors have said that there are quite a number of other companies who are in the situation that we’re in and are very long into the application process, can be as much as two years like we are. It’s not just us. That is a comfort factor, and it was helpful to hear that from our advisors. I don’t have firsthand knowledge, but they’re experts and they see the landscape.

If this second hand transcript is correct, LP really really highlighted the risk factors like she hasn’t before, I noticed.

>>You should read our SEC filings that contain a non-exhaustive list of risk factors. There are lots of factors, risk factors, and other factors that can cause actual results to differ materially from our forward-looking statements and whatever we may currently anticipate. So just solid, solid on the table and very clear for everyone.

Let me start by saying that this is going to be an informal discussion. It’s going to contain forward-looking statements. And we need to be clear in our disclaimer that all statements other than statements of historical fact are forward-looking statements. So we expect, we hope, we plan, we anticipate. All of these are forward-looking statements. You should not rely upon forward-looking statements.

https://justthenews.com/politics-policy/health/britains-health-service-becomes-poster-child-travails-big-government

Is it in here?

https://pmc.ncbi.nlm.nih.gov/articles/PMC12439551/

Oh, I don’t know, good oilfield practice? 🤷🏻‍♂️

>>Nobody knows what the count is... so why discuss it?

Does anyone here want to discuss the new employee count or isn’t it important?🤷‍♀️. Or are they all gone?🤔

>>I hope we don't see sizable jumps in OS this week

Which message board is the pump happening?

Hey DanishDud, please feed into your AI to ask what reason LP would feed 90 Advent mouths with mostly public NWBO contract revenue, then not go into great detail for shareholders of its financials upon takeover?

Yep. Terrible.

>>And bulk of that $25M is NWBO contract work, which doesn’t show up on the books anymore. Rather, they are considered expenses!

Maybe? There’s always a little bump in biotech the first week of the new year too.

$25M is bs for a ten year old CDMO with cryo services. I was expecting at least 3X that.

Anyone recall LG’s options strike, was it 22 cents on up to 40 cents?

It’s nebulous as always, so we need to see 2025 financials. But the lack of revenue for a ten year old facility is a major problem.

“Clear as mud”…Seems to be the routine with this company.

With no Advent revenues and continued silence and avoidance expect ten cents or less.

Will be interesting to see if this little bounce is Les’ trust escape?

Nothing normal about allegedly running a Specials program for ten years, a study program at UCLA for twenty years, then taking a break for three years preparing a MAA, then waiting two plus year for a verdict on a therapy with few side effects but with just one trial in a devastating disease that kills children and adults so quickly. The entire thing is preposterous!

Nothing is normal about this MAA submission so don’t expect anything normal with CHM or MHRA in terms of a verdict, imo.🤷‍♀️. Wouldn’t surprise me to hear nothing in 2026.

Not related party but they’ve got to have serious Accounts receivables, or they had better.

Good. 👍

“hypothesis”

So where is it, or are you saying it’s a loss on paper only?

Balance
2022 y/e 15.4M
2023 y/e 7.6M
2024 y/e 20.3M loss

Y/e 2024 Balance $2.7M

…Administrative expenses went from 7.7M to 30.3M in one year.

So you’re saying there were practically no revenues in this ten year old CDMO with a staff of 90 and allegedly state of the art facility including cryo storage?

You just blew out the boiler room’s super computer circuits.🤣

>>Its not too difficult to comprehend. They have made a ton of money betting against lies and timing inaccuracies of NWBO. And they expect to do so in the coming years! ;)

On the other hand, the so called longs over the last 10+ years have seen 2 generation of bag holders wiped off, over 95% loss in value, and endure the biggest opportunity cost (golden decade of stock return). It’s difficult to find a reason for this ongoing behavior of so called longs, LOL!

What about the revenues from other customers and cryo?

>>by Advent over the last several years.
Intellectual property and other intangibles that Advent had acquired are also included.” — NWBIO

So far as I know, Tuscan’s only business was owning Advent, so now what do they do?

It wasn’t an “Accusation” you dope. Stop trying to muzzle concerned investors. Given her endless silence this is what we’re left to do - Guessing various scenarios. It’s healthy investment talk to keep from getting one's pockets cut out.

I guess we should then see Tuscan close up? Will watch.

😂 I asked Dbing to post his simple correspondence requesting management buy back his stock, but he couldn’t.

LOL. That’s a pretty ballsy statement made by AF involving UCLA and Liau. He had to dot all his i to post that one, imo.

AF on X:
The question you should be asking: "Is @UCLAHealth and Dr. Linda Liau complicit in the $NWBO DCVax masquerade?" Liau was the principal investigator of the failed Ph3 study. She's also a member of Northwest Bio's scientific advisory board.

That’d be my guess. The minority partners in Toucan had to get something. And there’s always the possibility that Toucan is now the owner of some new CDMO business sprung off from Advent?

Does a Boiler room count? 😂

>>Administrative expenses are the costs incurred by a company to manage and support its operations, which are not directly tied to producing goods or services. These expenses typically include salaries of administrative staff,

For the life of me I can’t understand why Advent Sawston’s cryo business isn’t thriving?

https://www.adventbio.uk/coldstorage